UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549


FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  June 29, 2011


MWI VETERINARY SUPPLY, INC.

(Exact name of registrant as specified in its charter)



Delaware
 
000-51468
 
02-0620757
 
(State or other jurisdiction of
Incorporation)
 
(Commission File
Number)
 
(I.R.S. Employer
Identification No.)
 


3041 W. Pasadena Dr. Boise, Idaho 83705

(Address of principal executive offices)   (Zip Code)

(208) 955-8930

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

q  
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

q  
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

q  
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

q  
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 

 


 
 
 

 
Item 1.01                      Entry into a Material Definitive Agreement

MWI Veterinary Supply Co. (“MWI”), a wholly-owned subsidiary of MWI Veterinary Supply, Inc., and Pfizer, Inc. (“Pfizer”) have entered into the 2011 Pfizer Equine Products Marketing Agreement, effective January 1, 2011, which was executed and delivered by Pfizer to MWI on June 29, 2011.
 
Under the 2011 Pfizer Equine Products Marketing Agreement, MWI is entitled to distribute certain Pfizer products to customers in the equine field.  In return, MWI is entitled to receive certain service incentives and rebates.  MWI is required to maintain sufficient staffing levels of sales representatives and store and handle inventory under appropriate conditions that will maintain the quality and integrity of the products.  The agreement expires on December 31, 2011 and can be terminated by either party with or without cause upon thirty days prior written notice.
 


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

         MWI VETERINARY SUPPLY, INC.
 
Date:  June 30, 2011
 
 
By:
 
/s/ Mary Patricia B. Thompson
     
Mary Patricia B. Thompson
     
Senior Vice President and Chief Financial Officer